The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Biopharmaceutical classification of poorly soluble drugs with respect to “enabling formulations”
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430 · cited 1×
“Drug bioavailability prediction relies on the principles originally laid down in the Biopharmaceutical Classification Scheme (BCS, Amidon et al., 1995).”
Lipids and Lipid-Based Formulations: Optimizing the Oral Delivery of Lipophilic Drugs
Porter, C. J. H., Trevaskis, N. L., & Charman, W. N. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2197 · Cited by 1,824
Dissolution Testing as a Prognostic Tool for Oral Drug Absorption: Immediate Release Dosage Forms
Dressman, J. B., Amidon, G. L., Reppas, C., & Shah, V. P. (1998) · Pharmaceutical Research · doi:10.1023/a:1011984216775 · Cited by 1,097
Miller, J. M., Beig, A., Krieg, B. J., Carr, R. A., Borchardt, T. B., Amidon, G. E., Amidon, G. L., & Dahan, A. (2011) · Molecular Pharmaceutics · doi:10.1021/mp200181v · Cited by 204
Cited by
McClements, D. J. (2015) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2015.02.002 · Cited by 449
Boyd, B. J., Bergström, C. A. S., Vinarov, Z., Kuentz, M., Brouwers, J., Augustijns, P., Brandl, M., Bernkop-Schnürch, A., Shrestha, N., Préat, V., et al. (2019) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2019.104967 · Cited by 367
Self-citationMechanisms of increased bioavailability through amorphous solid dispersions: a review
Schittny, A., Huwyler, J., & Puchkov, M. (2020) · Drug Delivery · doi:10.1080/10717544.2019.1704940 · Cited by 343
PBPK models for the prediction of in vivo performance of oral dosage forms
Kostewicz, E. S., Aarons, L., Bergstrand, M., Bolger, M. B., Galetin, A., Hatley, O., Jamei, M., Lloyd, R., Pepin, X., Rostami-Hodjegan, A., et al. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.09.008 · Cited by 315
Choi, S. J., & McClements, D. J. (2020) · Food Science and Biotechnology · doi:10.1007/s10068-019-00731-4 · Cited by 298
Drug permeability profiling using cell-free permeation tools: overview and applications
Berben, P., Bauer-Brandl, A., Brandl, M., Faller, B., Flaten, G. E., Jacobsen, A.-C., Brouwers, J., & Augustijns, P. (2018) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2018.04.016 · Cited by 199
Self-citationDesign of Functional Therapeutic Deep Eutectic Solvents Based on Choline Chloride and Ascorbic Acid
Silva, J. M., Reis, R. L., Paiva, A., & Duarte, A. R. C. (2018) · ACS Sustainable Chemistry & Engineering · doi:10.1021/acssuschemeng.8b01687 · Cited by 142
Bibi, H. A., Holm, R., & Bauer-Brandl, A. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.05.001 · Cited by 68
“Drug molecules solubilized inside these micelles and in other colloidal structures present in the gastro intestinal fluids first need to be released from such structures and become freely (truly) molecularly dissolved, before their uptake [4].”
BackgroundPermeaLoop™, a novel in vitro tool for small-scale drug-dissolution/permeation studies
Sironi, D., Rosenberg, J., Bauer-Brandl, A., & Brandl, M. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2018.04.042 · Cited by 36
Self-citationIlie, A.-R., Griffin, B. T., Brandl, M., Bauer-Brandl, A., Jacobsen, A.-C., Vertzoni, M., Kuentz, M., Kolakovic, R., & Holm, R. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105452 · Cited by 33
Self-citation
Metadata
- Authors
- Buckley, S. T., Frank, K. J., Fricker, G., & Brandl, M.
- Venue
- European Journal of Pharmaceutical Sciences
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 50
- Issue
- 1
- Pages
- 8-16
- ISSN
- 0928-0987 (ISSN-L)
- OpenAlex
- W2164246656
- Cited by
- 213
- References
- 4
- FWCI
- 7.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.